Profile data is unavailable for this security.
About the company
3-D Matrix, Ltd. is a company engaged in the research, development, manufacture and sale of medical products. The Company has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.
- Revenue in JPY (TTM)8.47bn
- Net income in JPY6.47m
- Incorporated2004
- Employees114.00
- Location3-D Matrix Ltd7FKojimachi HF Bldg., 3-2-4, Koji-machiCHIYODA-KU 102-0083JapanJPN
- Phone+81 335113440
- Fax+81 335113402
- Websitehttps://www.3d-matrix.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharma Foods International Co., Ltd. | 66.38bn | -1.88bn | 18.99bn | 613.00 | -- | 2.01 | -- | 0.2861 | -64.99 | -64.99 | 2,293.41 | 324.90 | 2.02 | 1.70 | 15.01 | 108,280,600.00 | -5.74 | 6.92 | -16.01 | 18.90 | 80.32 | 80.70 | -2.84 | 3.34 | 0.6512 | -8.21 | 0.6151 | 33.24 | 5.01 | 33.56 | -88.52 | -11.84 | -0.161 | 24.08 |
| AnGes Inc | 874.12m | -5.23bn | 23.74bn | 55.00 | -- | 7.59 | -- | 27.16 | -15.21 | -15.21 | 2.46 | 7.91 | 0.1735 | 0.3487 | 8.45 | -- | -103.74 | -49.52 | -189.41 | -59.16 | 36.65 | 31.53 | -597.83 | -3,839.32 | 1.18 | -23.87 | 0.0174 | -- | 35.81 | 85.31 | 81.42 | -- | -29.27 | -- |
| Heartseed Inc | -100.00bn | -100.00bn | 45.49bn | 39.00 | -- | 6.32 | -- | -- | -- | -- | -- | 314.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.15 | -- | 0.00004 | -- | -- | -- | -- | -- | -- | -- |
| Healios KK | 104.00m | -2.22bn | 51.57bn | 65.00 | -- | 9.04 | -- | 495.87 | -25.70 | -25.70 | 0.9661 | 42.25 | 0.0067 | -- | 0.4952 | -- | -14.27 | -23.01 | -18.09 | -30.33 | -109.62 | -- | -2,143.27 | -2,221.73 | -- | -- | 0.5993 | -- | -81.43 | 30.96 | 47.65 | -- | -11.70 | -- |
| Shin Nippon Biomedical Laboratories Ltd | 31.37bn | 3.99bn | 69.90bn | 1.44k | 17.52 | 1.32 | 9.82 | 2.23 | 95.84 | 95.84 | 753.61 | 1,269.67 | 0.2983 | 1.01 | 5.59 | 21,848,400.00 | 3.73 | 9.90 | 5.31 | 14.82 | 51.59 | 52.68 | 12.50 | 23.35 | 0.6308 | -- | 0.4383 | 30.49 | 22.55 | 17.36 | -10.96 | 14.07 | 54.79 | 58.49 |
| 3-D Matrix Ltd | 8.47bn | 6.47m | 73.58bn | 114.00 | -- | 18.45 | 96.11 | 8.69 | -2.67 | -2.67 | 71.61 | 32.90 | 1.25 | 0.9849 | 4.61 | 74,276,300.00 | 0.0958 | -35.52 | 0.1222 | -46.12 | 68.67 | 59.66 | 0.0764 | -55.66 | 2.53 | -- | 0.2619 | -- | 51.11 | 59.47 | -878.94 | -- | -7.64 | -- |
| Takara Bio Inc | 44.15bn | -7.20bn | 114.52bn | 1.78k | -- | 1.13 | -- | 2.59 | -59.79 | -59.79 | 366.64 | 839.16 | 0.3535 | 1.48 | 5.49 | 24,816,750.00 | -5.73 | 8.66 | -6.12 | 9.70 | 53.99 | 63.76 | -16.20 | 17.16 | 3.83 | -4.82 | 0.0898 | 31.40 | 3.53 | 5.44 | -29.59 | -22.88 | 20.46 | 16.27 |
| GNI Group Ltd | 26.84bn | -4.41bn | 143.66bn | 867.00 | -- | 2.86 | -- | 5.35 | -80.69 | -80.69 | 511.58 | 900.92 | 0.3447 | 2.18 | 4.01 | -- | -9.40 | 0.5414 | -11.37 | 0.6475 | 74.49 | 80.97 | -27.26 | 1.28 | 3.79 | -2.99 | 0.0941 | -- | 13.67 | 22.39 | -501.65 | -- | 34.24 | -- |
| SanBio Co Ltd | 0.00 | -3.44bn | 176.04bn | 29.00 | -- | 330.15 | -- | -- | -48.26 | -48.26 | 0.00 | 6.83 | 0.00 | -- | -- | 0.00 | -138.65 | -47.32 | -177.12 | -57.01 | -- | -- | -- | -- | -- | -12.42 | 0.725 | -- | -- | -- | -9.02 | -- | -46.04 | -- |
| Peptidream Inc | 18.52bn | -3.75bn | 203.92bn | 621.00 | -- | 3.93 | -- | 11.01 | -28.99 | -28.99 | 143.24 | 398.78 | 0.2182 | 3.75 | 3.32 | -- | -4.42 | 8.02 | -5.86 | 9.72 | 40.61 | 64.82 | -20.24 | 18.77 | 1.53 | -16.77 | 0.2485 | 0.00 | -60.32 | 9.66 | -124.97 | -- | 24.52 | -- |
Data as of Feb 17 2026. Currency figures normalised to 3-D Matrix Ltd's reporting currency: Japanese Yen JPY
0.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Heights Capital Management, Inc.as of 02 Feb 2026 | 469.08k | 0.39% |
| Simplex Asset Management Co., Ltd.as of 05 Feb 2026 | 273.50k | 0.23% |
| Curio Wealth LLCas of 31 Dec 2025 | 38.90k | 0.03% |
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
